Lawrence Cull Jr., PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 57 Howard Gap Rd, Fletcher, NC 28732 Phone: 828-483-4330 Fax: 828-483-5417 |
Madelon Jean Parks, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 455 Concord Rd, Fletcher, NC 28732 Phone: 828-329-8306 Fax: 828-258-3831 |
Brittany Lee Lance, LPA Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 5010 Hendersonville Rd, Fletcher, NC 28732 Phone: 828-884-2475 |
News Archive
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help physicians make better treatment choices for patients with gastric and esophageal adenocarcinoma.
From Finland to Italy and from Spain to Lithuania, thirteen research institutes from eleven European countries took part in the three-year Hialine study. The coordinator was Professor Dr Jeroen Buters of TUM's Chair of Molecular Allergology and the Center of Allergy & Environment.
The University of Texas at San Antonio (UTSA) released its newest research numbers today, reporting a 34% increase to $46,521,487 in total research spending for the Sept. 1, 2008 – Aug. 31, 2009 fiscal year (FY 09) over the previous fiscal year, when research spending totaled $34,601,444. The statistic is up 97% from just five years ago, when UTSA's total research expenditures were $23,605,844.
GlaxoSmithKline has announced that it has entered into an agreement to divest full commercial rights to Wellbutrin XL in the United States to Biovail International Laboratories SRL, a subsidiary of Biovail Corporation, for $510 million (euro 340 million). The agreement is subject to Hart-Scott-Rodino regulatory clearance in the United States.
› Verified 7 days ago